Rosenberg Matthew Hamilton Gilead Sciences, Inc. Transaction History

Rosenberg Matthew Hamilton

$378 Million
Q3 2024

A detailed history of Rosenberg Matthew Hamilton transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 2,168 shares of GILD stock, worth $195,531. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,168

Previous 2,168 -0.0%

Holding current value

$195,531

Previous $148,000 22.3%

% of portfolio

0.05%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$71.58 - $87.29 $4,080 - $4,975	57 Added 2.7%	2,168 $158,000
Q4 2023 Jan 12, 2024	SELL	$73.27 - $83.09 $2,857 - $3,240	-39 Reduced 1.81%	2,111 $171,000
Q3 2023 Oct 11, 2023	BUY	$73.94 - $80.67 $4,140 - $4,517	56 Added 2.67%	2,150 $161,000
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $3,192 - $3,641	42 Added 2.05%	2,094 $161,000
Q1 2023 Apr 17, 2023	BUY	$77.31 - $88.08 $77 - $88	1 Added 0.05%	2,052 $170,000
Q4 2022 Jan 18, 2023	BUY	$62.32 - $89.47 $4,113 - $5,905	66 Added 3.32%	2,051 $0
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $3,155 - $3,604	53 Added 2.74%	1,985 $122,000
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $4,098 - $4,615	71 Added 3.82%	1,932 $120,000
Q1 2022 Apr 14, 2022	BUY	$57.92 - $72.58 $70,952 - $88,910	1,225 Added 192.61%	1,861 $111,000
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $15,311 - $17,379	-236 Reduced 27.06%	636 $46,000
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $23,556 - $25,414	348 Added 66.41%	872 $61,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $3,871 - $4,230	-61 Reduced 10.43%	524 $36,000
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $9,360 - $10,679	156 Added 36.36%	585 $28,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $76,420 - $87,077	-1,349 Reduced 75.87%	429 $25,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $58,808 - $73,941	-947 Reduced 34.75%	1,778 $112,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $42,246 - $49,056	584 Added 27.28%	2,725 $210,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $134,090 - $171,751	2,141 New	2,141 $161,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.

Account

Rosenberg Matthew Hamilton Gilead Sciences, Inc. Transaction History